BRISTOL-MYERS SQUIBB.(Bristol-Myers Squibb Cp. acquires Dong-A Biotech Co.)(Business Brief)(Brief Article)

Chemical Market Reporter, November, 1998

BRISTOL-MYERS SQUIBB has signed an agreement to acquire Dong-A Biotech Co., a subsidiary of Dong-A Pharmaceutical Co. Ltd, Seoul, South Korea. Dong Biotech Co. markets and sells pharmaceuticals licensed from Bristol-Myers Squibb, including Taxol (paclitaxel), Cefzil (cefprozil), Azactam (aztreonam) and a range of cardiovascular products.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement